About Peloton Pharmaceuticals
Peloton Pharmaceuticals was founded in 2013 and is based in Pointe-Claire, Canada. Operations focus on the cannabis industry, where production services are delivered for pharmaceutical applications. The company handles cultivation, processing, and related manufacturing processes to support cannabis-based products. Leadership is provided by CEO Miguel Martin, with activities centered in the Canadian market to meet regulatory standards in the sector.
- Headquarter Pointe-claire, Canada
-
Sectors
Healthcare
-
Phone
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Aurora Cannabis
(Mar 06, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Peloton Pharmaceuticals
Detailed funding history for Peloton Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Peloton Pharmaceuticals
Peloton Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Aurora Cannabis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Medical marijuana is produced and distributed by Aurora Cannabis.
|
Locked | Locked | Locked |
Investor details for Peloton Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Peloton Pharmaceuticals
Investment portfolio details for Peloton Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Peloton Pharmaceuticals
Detailed financials for Peloton Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Peloton Pharmaceuticals Comparisons
Peer comparison for Peloton Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Peloton Pharmaceuticals
Detailed competitors of Peloton Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Peloton Pharmaceuticals
Complete news archive for Peloton Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Peloton Pharmaceuticals
Peloton Pharmaceuticals was founded in 2013.
Peloton Pharmaceuticals is headquartered in Pointe-claire, Canada. It is registered at Pointe-claire, Quebec, Canada.
Miguel Martin is the current CEO of Peloton Pharmaceuticals.
Peloton Pharmaceuticals was founded in 2013 and is based in Pointe-Claire, Canada. Operations focus on the cannabis industry, where production services are delivered for pharmaceutical applications. The company handles cultivation, processing, and related manufacturing processes to support cannabis-based products. Leadership is provided by CEO Miguel Martin, with activities centered in the Canadian market to meet regulatory standards in the sector.
Peloton Pharmaceuticals has 1 investor. Key investors include Aurora Cannabis.